Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy
Genetical, Multi-center, Prospective Study of Phenotyping and Genotyping of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy in the Aim of the Realisation of a Clinical Trial of Gene Therapy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
- Procedure: realization of a family tree
- Procedure: refractometry
- Procedure: evaluation of the presence of a nystagmus
- Procedure: ocular behavior
- Procedure: test of baby vision
- Procedure: test of keenness
- Procedure: reading test
- Procedure: visual field
- Procedure: color vision
- Procedure: electroretinographical activity
- Procedure: biomicroscopical test
- Procedure: retinal imaging
- Procedure: retinal autofluorescence
- Procedure: genotyping
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nantes, France, 44093
- CHU de Nantes
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with clinical characteristics of amaurosis of Leber
- Patients suffering from an early severe retinal dystrophy
- Patients with social insurance
- Patients with a consent form signed
Exclusion Criteria:
- Retinal dystrophy with autosomal dominant transmission
- Retinal dystrophy occuring after 5 years of age
- Syndromical retinal dystrophy with one or more systemic manifestations
- Familial macular degeneration
- Familial choroid dystrophy
- Non-degenerative retinopathology
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Michel Weber, MD, CHU de Nantes
- Principal Investigator: Sabine Defoort, MD, CHU de Lille
- Principal Investigator: Bernard Puech, MD, CHU de Lille
- Principal Investigator: Isabelle Drumaré, MD, CHU de Lille
- Principal Investigator: Christian Hamel, MD, CHU de Montpellier
- Principal Investigator: Carl Arndt, MD, CHU de Montpellier
- Principal Investigator: Olivier Roche, MD, Hopital Necker
- Principal Investigator: Christophe Orssaud, MD, Hopital Necker
- Principal Investigator: Emmanuel Bui Quoc, MD, Hopital Necker
- Principal Investigator: Saddek Mohand Saïd, MD, CNO XV-XX
- Principal Investigator: José-Alain Sael, MD, CNO XV-XX
- Principal Investigator: Hélène Dollfus-Waltmann, MD, CHU de Strasbourg
Study record dates
Study Major Dates
Study Start
Study Start
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BRD 06/8-F
- ID RCB 2006-A00192-49
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.